University Hospital, Bordeaux
Clinical trials sponsored by University Hospital, Bordeaux, explained in plain language.
-
Diabetes drug could boost arthritis treatment
Disease control OngoingThis study is testing whether adding the diabetes medication metformin to standard methotrexate treatment works better for controlling rheumatoid arthritis. Researchers want to see if the combination helps more patients achieve remission compared to methotrexate alone. The trial …
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Double-Duty attack on arthritis: can two drugs beat one?
Disease control OngoingThis study is for people with rheumatoid arthritis (RA) who haven't gotten enough relief from their current biologic or targeted drugs. It's testing if taking two powerful medications together—baricitinib and an anti-TNF drug—works better to control the disease than taking just b…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Doctors test best way to fight lung cancer that spreads to brain
Disease control OngoingThis study aims to find the best treatment approach for patients with non-small cell lung cancer that has spread to the brain in a limited way (fewer than 5 spots). Researchers are comparing two strategies: treating the main tumor and brain spots directly versus using body-wide m…
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New drug duo aims to outsmart tough cancers in kids & adults
Disease control OngoingThis study is testing whether combining two drugs, spartalizumab and pazopanib, can help control advanced solid tumors that have come back or stopped responding to standard treatments. It will enroll about 80 children and adults to find the safest dose for kids and see if the com…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
VR goggles aimed at healing minds after bodies change
Symptom relief OngoingThis study is testing whether virtual reality (VR) therapy can help people feel better about their bodies after they have had major weight loss (bariatric) surgery. It compares a special VR program designed to help patients accept their new body shape against the standard follow-…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Mar 18, 2026 14:40 UTC
-
Brain scans unlock mystery of MS memory loss
Knowledge-focused OngoingThis study aims to understand how thinking and memory problems develop over time in people with primary progressive multiple sclerosis (PPMS). Researchers will follow 66 participants for 2 years, using brain scans and detailed thinking tests to see how brain changes relate to cog…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
Massive 90,000-Person study questions routine heart checks for diabetics
Knowledge-focused OngoingThis study aims to find out if routinely screening for hidden heart disease in people with type 2 diabetes who are at very high risk is a good use of healthcare resources. Researchers will analyze the health records of 90,000 French patients to compare the costs and outcomes of t…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:58 UTC
-
Scientists hunt for hidden clues to lupus Patients' heart attack risk
Knowledge-focused OngoingThis study aims to find better ways to identify which people with lupus are most likely to develop heart disease. Researchers will follow 500 adult lupus patients, measuring specific substances in their blood and using ultrasound to track artery health over time. The goal is to d…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Major european hunt for clues to stop dangerous virus in transplant patients
Knowledge-focused OngoingThis study aims to understand why some organ transplant patients develop severe, hard-to-treat Cytomegalovirus (CMV) infections. Researchers are collecting blood samples and health data from over 550 transplant patients across Europe. By studying these samples, they hope to ident…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC